Abbott Laboratories

ABT
NYSE
Last Updated: 12/5/2022 9:03:28 PM
Price
105.41
Changes
-2.68
% Change
-2.48
Volume
4218088
52 Week
High
142.6
52 Week
Low
93.25
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Abbott Laboratories Company Details
CEO:   Mr. Robert Ford
Country:   US
Industry:   Medical Devices
Website:   https://www.abbott.com
Exchange:   New York Stock Exchange
IPO\Launch Date:   1937-03-01
Abbott Laboratories Company Executive Details
  Ms. Elaine R. Leavenworth
  Senior Vice President and Chief Marketing & External Affairs Officer
  Ms. Melissa Brotz
  Vice President of Public Affairs & Corporation Marketing
  James E. Young
  Vice President and Chief Ethics & Compliance Officer
  Mr. Scott Michael Leinenweber
  Vice President of Investor Relations, Licensing & Acquisitions
  Mr. Gregory A. Ahlberg
  Senior Vice President of Core Laboratory Diagnostics & Commercial Operations

Abbott Laboratories Latest News

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?


Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.


Published on: 2022-11-28 10:32:32

Impact on Symbol / Company: ABT

View News

Is This Stock-Split Stock a Buy For 2023?


Don't buy this company's shares for its recent stock split.


Published on: 2022-11-26 10:00:00

Impact on Symbol / Company: ABT

View News

This Robotic Surgical Company Is Likely To Offer Better Returns Over Abbott Stock


We believe Intuitive Surgical stock is currently a better pick than Abbott stock, given its better prospects. Although Abbott is trading at a comparatively lower valuation of 4.1x trailing revenues vs. 15.2x for Intuitive Surgical, this gap in the valuation is justified mainly given the latter's superior revenue growth and lower financial risk, as discussed below.


Published on: 2022-11-25 09:00:00

Impact on Symbol / Company: ABT

View News

2 Unbeatable Dividend Stocks Billionaires Keep Buying in a Bear Market


Some of the world's most successful investors made big bets on these dividend payers recently.


Published on: 2022-11-25 05:31:00

Impact on Symbol / Company: ABT

View News

Abbott Laboratories: Good Execution And Attractive Valuation


Abbott is a market leader in medical device businesses such as vascular care and diabetes care. It also leads in the in-vitro diagnostic market. The likely decline of COVID testing heavily impacted the share price.


Published on: 2022-11-24 03:37:13

Impact on Symbol / Company: ABT

View News

Good Stocks To Invest In Now? 3 Dividend Aristocrats Stocks For Your List


Check out these three dividend aristocrats in the stock market this week.


Published on: 2022-11-22 06:30:00

Impact on Symbol / Company: ABT

View News

Want Passive Income in 2023? Buy These Dividend Kings


These stocks offer you a gift: recurrent income just for owning them.


Published on: 2022-11-22 06:00:00

Impact on Symbol / Company: ABT

View News

4 Growth Stocks To Buy As Inflation Cools


Inflation cooled more than expected recently. It could be the first sign of a different rate environment and a bullish stock market. These four stocks should profit either way due to their strong growth, profitable cash flows, and shareholder returns.


Published on: 2022-11-21 13:17:13

Impact on Symbol / Company: ABT

View News

Abbott Laboratories: Prepare For A Tough 2023


The stock of Abbott Labs is down 18%+ over the past 12 months and has significantly underperformed the broad healthcare sector. This is likely not what investors expected - typically a healthcare stock like Abbott would outperform during an inflationary bear market.


Published on: 2022-11-21 01:01:03

Impact on Symbol / Company: ABT

View News

Abbott (ABT) Up 7.7% Since Last Earnings Report: Can It Continue?


Abbott (ABT) reported earnings 30 days ago. What's next for the stock?


Published on: 2022-11-18 12:56:14

Impact on Symbol / Company: ABT

View News

Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?


Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.


Published on: 2022-11-15 10:32:28

Impact on Symbol / Company: ABT

View News

7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond


While it's tempting to target the flavors of the week during a market correction, investors ought to spare some time for no-brainer blue-chip stocks to buy for 2023 and beyond. Indeed, the broader market and economic dynamics encourage retail investors to think about value and stability over growth.


Published on: 2022-11-12 12:05:09

Impact on Symbol / Company: ABT

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you